Response to Comments: Transurethral Waterjet Ablation of the Prostate

This document is a response-to-comments for the proposed LCD on transurethral waterjet ablation of the prostate; it does not establish specific clinical coverage criteria in this text. Policy decisions are based on evidence of general acceptance per CMS Program Integrity Manual Chapter 13, prioritizing peer-reviewed research, systematic reviews, meta-analyses, and clinical guidelines, while anecdotal or unpublished information has limited influence.

"Anecdotal or unpublished information not subject to peer review will have limited influence on policy determinations and should not be relied upon as primary evidence for coverage decisions."

Sign up to see full coverage criteria, indications, and limitations.